FDA label
What is Zurzuvae used for?
Zurzuvae contains zuranolone. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “ZURZUVAE is indicated for the treatment of postpartum depression (PPD) in adults.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Zurzuvae?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Zurzuvae, capsule
Indications and Usage, quoted from the label by Biogen MA Inc. (NDA217369). Cross-references to other label sections are left out.
ZURZUVAE is indicated for the treatment of postpartum depression (PPD) in adults.
Source: DailyMed label, set id f18e53b0-d0bb-422d-8de7-ab64b7292b29, version 18, effective June 15, 2026. NDC 64406-029, one of 3 listings for this product.
Questions
What is Zurzuvae used for?
The FDA label says: “ZURZUVAE is indicated for the treatment of postpartum depression (PPD) in adults.”
What drug class is Zurzuvae?
FDA lists zuranolone in the Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Zurzuvae
- Is Zurzuvae a controlled substance?Schedule IV
- Generic for ZurzuvaeFDA Orange Book
- Is Zuranolone a controlled substance?Schedule IV
- Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulators listFDA drug class
- NDC 64406-029Zurzuvae NDC record
- NDC 64406-030Zurzuvae NDC record
- NDC 64406-031Zurzuvae NDC record
- Schedule IV drugs listDEA schedule